Generation Bio
Stock Forecast, Prediction & Price Target
Generation Bio Financial Estimates
Generation Bio Revenue Estimates
Generation Bio EBITDA Estimates
Generation Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $5.90M 0% | Avg: $5.44M Low: $3.07M High: $7.81M avg. -7.71% | Avg: $6.93M Low: $3.34M High: $10.24M avg. 27.32% | Avg: $5.8M Low: $2.79M High: $8.56M avg. -16.39% | Avg: $11.6M Low: $5.59M High: $17.12M avg. 100% |
Net Income
% change YoY
| $-114.66M N/A | $-132.09M -15.19% | $-126.61M 4.15% | Avg: $-68.76M Low: $-83.18M High: $-32.88M avg. 45.68% | Avg: $-65.99M Low: $-79.31M High: $-23.22M avg. 4.02% | Avg: $-48.68M Low: $-78.85M High: $-15.92M avg. 26.23% | Avg: $-56.74M Low: $-91.90M High: $-18.56M avg. -16.55% |
EBITDA
% change YoY
| $-119.10M N/A | $-141.18M -18.53% | $-133.3M 5.58% | Avg: $3.26M Low: $1.84M High: $4.69M avg. 102.45% | Avg: $4.16M Low: $2.00M High: $6.14M avg. 27.32% | Avg: $3.48M Low: $1.67M High: $5.13M avg. -16.39% | Avg: $6.96M Low: $3.35M High: $10.27M avg. 100% |
EPS
% change YoY
| -$2.04 N/A | -$2.27 -11.27% | -$1.96 13.65% | Avg: -$0.96 Low: -$1.29 High: -$0.51 avg. 51.09% | Avg: -$0.73 Low: -$1.23 High: -$0.36 avg. 24.36% | Avg: -$0.76 Low: -$1.22 High: -$0.25 avg. -4.13% | Avg: -$0.88 Low: -$1.43 High: -$0.29 avg. -16.55% |
Operating Expenses
% change YoY
| $119.10M N/A | $141.18M 18.53% | $144.46M 2.32% | Avg: $13.74M Low: $7.75M High: $19.72M avg. -90.48% | Avg: $17.50M Low: $8.44M High: $25.84M avg. 27.32% | Avg: $14.63M Low: $7.05M High: $21.60M avg. -16.39% | Avg: $29.26M Low: $14.11M High: $43.20M avg. 100.00% |
FAQ
What is Generation Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 14.84% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -83.18M, average is -68.76M and high is -32.88M.
What is Generation Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 25.80% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $3.07M, average is $5.44M and high is $7.81M.
What is Generation Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 13.69% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.29, average is -$0.96 and high is $-0.51.